Submit manuscript...
eISSN: 2574-9838

International Physical Medicine & Rehabilitation Journal

Research Article Volume 3 Issue 6

Impact of pruritus on quality of life in patients with tinea

Sevil Bicer,1 Yilmaz Ulas,2 Mustafa Atasoy,3 Kemal Ozyurt,4 Safiye Ulas,5 Ragip Ertas,2 Atil Avci2

1Assistant Professor, Department of Nursing, Erciyes University Faculty of Health Sciences, Turkey
2Department of Dermatology, Saglik Bilimleri University, Turkey
3Professor, Department of Dermatology, Saglik Bilimleri University, Turkey
4Assocciate Professor, Department of Dermatology, Saglik Bilimleri University, Turkey
5Department of Hematology, Saglik Bilimleri University, Turkey

Correspondence: Sevil Biçer, Department of Nursing, Erciyes University Faculty of Health Sciences, Kayseri, Turkey, Tel 03522076666/58568, Fax 3524379281

Received: November 29, 2018 | Published: December 12, 2018

Citation: Biçer S, Ulai Y, Atasoy M, et al. Impact of pruritus on quality of life in patients with tinea. Int Phys Med Rehab J. 2018;3(6):534-538. DOI: 10.15406/ipmrj.2018.03.00160

Download PDF

Abstract

Purpose: The aim of this study was to determine descriptively the impact of pruritus on quality of life in patients with tinea pedis.

Methods: The study included 214 patients referring to dermatology outpatient clinic at Kayseri Research and Teaching Hospital between May 2016 and August 2016 with diagnosis of tinea pedis and meeting the inclusion criteria. Study data was collected by face to face interview with patients via survey form and Dermatological Quality of Life Index (DLQI) and Modified Pruritus Index (MPI) used by two interviewers.

Results: Study included 95 females and 119males, in total 214 patients. Mean age was 45.6±16.42 years. In general mean score of subjects for both DLQI and MPI was 10.56±6.57 and 9.58±8.30, respectively. Mean DLQI and MPI score was higher in females, between age 50 and 59 years, in patients with disease for more than a year and in patients with diabetes mellitus. Mean DLQI and MPI score was increased with increasing number of disease-specific physical symptoms such as redness, pain, ache, burning and nail changes. Quality of life was negatively affected by increasing both level and severity of pruritus.

Conclusion: Mean DLQI and MPI score is significantly higher in patients with physical symptoms specific to tinea pedis. Mean DLQI and MPI score is increased with increasing severity of pruritus and in turn, this negatively affects quality of life.

Keywords: tinea pedis, pruritus, quality of life

Introduction

Superficial fungal infections are highly frequent in our country as well as on the world.1 Although tinea pedis with symptoms of pruritus, redness, exfoliation and maceration on the foot, especially at interdigital area, is not life-threatening and doesn’t lead to functional impairment, it negatively affects quality of life and relationship of patients with other people by leading to shaming, low self-esteem, loss of self-confidence, social timidity.2 Itching is one of the most intensely perceived symptoms and it is considered as one the main factors affecting quality of life.

Although tinea pedis is among the most frequently encountered dermatological diseases, number of studies on the effect on quality of life is very few.3 In studies done to measure the quality of life in dermatological diseases with pruritus, pruritus was suggested as main factor affecting quality of life.4,5 Therefore the aim of this study was to investigate the effect of pruritus on quality of life in patients with tinea pedis.

Methods

Participants

The sample group of study consisted of 214 patients referring to dermatology outpatient clinic at Kayseri Research and Teaching Hospital between May 2016 and August 2016 with diagnosis of tinea pedis and meeting the inclusion criteria.

Study included patients aged over 18 years who are volunteers, speaking and understanding Turkish language and those who are without communication problem.

Health related quality of life measurement

Study data was collected by face to face interview with patients via survey form and Dermatological Quality of Life Index (DLQI) and Modified Pruritus Index (MPI) used by two interviewers.

Survey form was developed by investigators following a literature search. This forms consisted from 6 questions related with “Socio-demographics” and “Disease related characteristics”.2–10

DLQI was developed by Finlay et al.11 and Turkish adaptation, validation and reliability study was done by Gürel et al.12 in 2005 and alpha reliability coefficient was calculated as 0.77-0.84. DLQI includes 10 questions and each question has answers of four options. Answers range from 0 to 3 and the evaluation is as following: 0= Not at all, 1=a little, 2=a lot, 3=very much. The sum of all answers is calculated to obtain DLQI. DLQI score is maximum 30 and minimum 0. As the score increases, quality of life reduces.

MPI was developed by Desai et al.13 and Turkish adaptation, validation and reliability study was done by Aksu et al.14 in 2007 and alpha reliability coefficient was calculated as 0.76- 0.94. In this study, Cronbach alpha coefficient was 0.840 and 0.920 for DLQI and MPI, respectively. MPI survey includes in total 18 answers and options for answers are “Not at all”, “a little”, “a lot” and “very much”. These options are assessed as “0”, “1”, “2” and “3”, respectively. MPI score is maximum 54 and minimum 0. Increasing score shows that pruritus affect negatively the subject.

Statistical analysis

Data were analyzed by S.P.S.S. 21.0 software and statistical evaluation included percentage calculation, Shapiro-Wilk normality test to analyze normal distribution of data, independent two samples t test for comparisons between groups, one-side variance analysis, Kruskal Wallis variance analysis and confidence analysis (cronbach alpha) tests.

Results

For patients included in the study, dermatological quality of life according to descriptive and disease related characteristics and distribution of mean score for modified pruritus index are shown in Table 1. Among 214 subject included in the study, 119 were males (55.6%) and 95 were females (44.4%); mean age was 45.6±16.42 years. Tinea pedis was most frequent in patients at age 50-59 years (46%). In 101 patients (47.2%), tinea pedis was present since 13 months and over. No systemic disease was present in 114 (53.3%) patients.

Demographics and disease related characteristics

Total (n=91)
n (%)

Dermatological quality of life index

p

modified pruritus index

p

Gender
Female
Male

 

95 (44.4)
119 (55.6)

 

11.83±7.04
9.54±6.00

 

t= 2.40
p= 0.016

 

10.67±7.06
8.72±6.11

 

t= 3.335
p= 0.001

Groups of age
20 years and younger
21-29 years
30-39 years
40-49 years
50-59 years
60 years and older

 

26 (12.1)
32 (15.0)
34 (15.9)
36 (16.8)
46 (21.5)
40 (18.7)

 

11.30±5.66
8.25±4.43
12.00±8.41
9.39±4.29
12.88±8.95
9.95±5.75

 

KW= 4.05
p= 0.542

 

10.07±7.55
7.81±5.45
12.52±6.77
8.30±4.67
13.22±10.51
6.40±4.40

 

KW= 14.423
p= 0.013

Mean age

45.60±16.42

Disease duration
0-6 months
7-12 months
13 months and older

 

84 (39.3)
29 (13.6)
101 (47.2)

 

9.50±5.90
10.86±7.15
12.58±5.60

 

KW= 6.723
p= 0.035

 

8.57±7.36
9.58±8.30
10.24±9.97

 

KW= 3.701
p= 0.157

Concomitant systemic disease
No systemic disease
Diabetes Mellitus
Hypertension
Congestive heart failure
Other

 

114 (53.3)
46 (21.5)
30 (14.0)
16 (7.5)
8 (3.7)

 

10.47±5.81
20.25±12.29
10.10±6.11
10.53±6.98
7.62±4.73

 

KW= 11.419
p= 0.022

 

8.91±6.66
28.25±17.58
7.43±5.49
11.60±9,52
7.50±4.35

 

KW= 14.077
p= 0.007

Table 1 Mean score distribution of dermatological quality of life index and modified pruritus index according to patient demographics and disease related characteristics

Mean DLQI and MPI score was higher in females, between age 50 and 59 years, in patients with disease for more than a year and in patients with diabetes mellitus (Table 1).

Mean DLQI and MPI score was higher in patients with physical symptoms such as redness, pain, swelling, ache, bleeding, exfoliation, pruritus, burning sensation at foot, scall on nail and nail thickness and the difference between them was statistically significant (p<0.05) (Table 2). As number of symptoms increased, DLQI and MPI mean scores were also increased, however difference was not significant (p˃0.05) (Table 3).

Physical symptoms

 

n (%)

Dermatological quality of life index

p

Modified pruritus index

p

Redness
Yes
None

 

130 (60.7)
84 (39.3)

 

11.80±7.22
8.64±4.87

 

t= 3.255
p= 0.001

 

10.89±9.37
7.57±5.80

 

t= 2.575
p= 0.010

Pain
Yes
None

 

74 (34.6)
140 (65.4)

 

12.89±8.00
9.32±5.30

 

t= 2.993
p= 0.003

 

11.29±9.21
8.68±7.66

 

t= 2.476
p= 0.013

Swelling
Yes
None

 

66 (30.8)
148 (69.2)

 

12.93±12.66
9.50±5.92

 

t= 3.706
p= 0.000

 

12.66±10.29
8.21±6.85

 

t= 3.374
p= 0.001

Ache
Yes
None

 

64 (29.9)
150 (70.1)

 

12.46±7.72
9.74±5.85

 

t= 2.466
p= 0.014

 

11.84±9.76
8.62±7.43

 

t= 2.819
p= 0.005

Bleeding
Yes
None

 

40 (18.7)
174 (81.3)

 

15.50±8.73
9.42±5.39

 

t= 4.219
p= 0.000

 

14.10±11.07
8.51±7.18

 

t= 3.725
p= 0.000

Exfoliation
Yes
None

 

134 (62.6)
80 (37.4)

 

12.14±7.25
7.90±4.04

 

t= 1.213
p= 0.225

 

10.82±9.48
7.52±5.27

 

t= 2.306
p= 0.021

Pruritus
Yes
None

 

162 (75.7)
52 (24.3)

 

10.88±6.78
9.55±5.80

 

t= 4.402
p= 0.000

 

10.58±8.72
6.50±5.94

 

t= 3.378
p= 0.001

Burning sensation at foot
Yes
None

 

128 (59.3)
86 (40.2)

 

11.37±6.68
9.34±6.24

 

t= 2.610
p= 0.009

 

10.10±8.12
8.81±8.55

 

t= 2.405
p= 0.041

Nail scoll
Yes
None

 

112 (52.3) 102 (47.7)

 

11.75±7.15
9.25±5.61

 

t= 2.465
p= 0.014

 

10.17±8.61
7.94±5.94

 

t= 1.268
p= 0.005

Nail thickening
Yes
None

 

137 (64.0)
77 (36.0)

 

11.43±6.68
9.01±6.11

 

t= 3.268
p= 0.001

 

9.94±8.56
7.96±4.85

 

t= 0.881
p= 0.048

Table 2 Mean score distribution of dermatological quality of life index and modified pruritus index according to disease related physical symptoms in patients

Number of symptoms

 

n (%)

Dermatological quality of life index

p

Modified pruritus index

p

0-3 Symptoms
4-6 Symptoms
7-10 Symptoms

65 (30.3)
74 (34.6)
75 (35.1)

10.50±7.00
10.87±6.04
10.96±6.57

 

KW= 0.322
p= 0.851

8.72±6.64
9.55±8.58
10.43±9.40

 

KW= 0.665
p= 0.717

Table 3 Mean score distribution of dermatological quality of life index and modified pruritus index according to disease related physical symptoms in patients

As severity of pruritus increased, mean score of DLQI and MPI was also increased and DLQI and MPI score was even higher in subjects with more severe pruritus and difference was statistically significant (p<0.05), (Table 4).

Severity of pruritus

n (%)

Dermatological quality of life index

p

Modified pruritus index

p

None

26 (12.1)

7.23±3.34

6.11±4.38

Mild

84 (39.3)

8.61±4.74

KW= 42.435

6.53±6.20

KW= 39.736

Moderate

54 (25.2)

10.70±5.87

p= 0.000

9.37±4.75

p= 0.000

Severe

50 (23.4)

17.00±7.53

17.24±11.75

Table 4 Mean score distribution of dermatological quality of life index and modified pruritus index according to severity of pruritus

In general, mean DLQI score was 10.56±6.57 and mean MPI score was 9.58±8.30 (Table 5). Strong (r=0.697) positive and significant correlation was detected between dermatological quality of life and modified pruritus index. As pruritus severity and level increased, quality of life was negatively affected (p< 0.001) (Table 6).

Scales

( x ¯ MathType@MTEF@5@5@+= feaagKart1ev2aqatCvAUfeBSjuyZL2yd9gzLbvyNv2CaerbdfwBIj xAHbstHrhAaeXatLxBI9gBaerbd9wDYLwzYbItLDharuavP1wzZbIt LDhis9wBH5garqqtubsr4rNCHbGeaGqkY=MjYJH8sqFD0xXdHaVhbb f9v8qqaqFr0xc9pk0xbba9q8WqFfeaY=biLkVcLq=JHqpepeea0=as 0Fb9pgea0lrP0xe9Fve9Fve9qapdbaqaaeGaciGaaiaabeqaamaaea qbaaGcbaGabmiEayaaraaaaa@402E@ ± SD)

Minimum – maximum values

Quality of Life Index

10.56± 6.57

0 - 30

Modified Pruritus Index

9.58± 8.30

0 - 54

Table 5 Mean score distribution of dermatological quality of life index and modified pruritus index in patients with tinea pedis

 

Dermatological quality of life index

Modified pruritus index

r

p

0.697

0.000

Table 6 Relationship between dermatological quality of life index and modified pruritus index in patients with tinea pedis

Discussion

Superficial fungal infections are highly frequent in our country as well as on the world.1 This disease is considered to affect about 20-25% of global population. Although it can occur in everywhere, a variability of 2.6- 56.8% was detected according to data from countries and regions.15

Tinea pedis is the most frequently seen clinical type of dermatophyte infections. In USA, tinea pedis infections are second condition of most frequently encountered dermatological diseases.16 About 1/10 of people are estimated to have tinea pedis at least once per their life time.6 In a study of Yıldırım and colleagues including 10100 dermatological patients, the rate was 17.5% and this was the most frequently seen superficial fungal diseases.3

Pruritus may be due to various etiologies and disturb the patient and it is the most relevant symptom of many dermatological and systemic diseases. Studies done for measuring quality of life in dermatological diseases with pruritus showed that pruritus was the main factor affecting quality of life.4,5

In studies on incidence of pruritus and its effect on quality of life, pruritus was more frequent in female patients and affected more quality of life.17,18 The reason was that severe anxiety and stress were more frequent in women, they were concerned more about how they are looking and they were more sensitive to changes in quality of life.19 In our study, we observed that pruritus was more frequent in women and affected more quality of life than man.

Skin diseases are frequently encountered health problems and vary according to age. Although all organs have certain changes during aging, skin is a visible organ and ageing-related changes are more remarkably observed and reduces quality of life of individual.20–22 In general it is well recognized that superficial fungal diseases and pruritus increase at middle and advanced age. In a serial of Yalçın et al.23 including 4099 patients, fungal infections were most frequently seen second dermatological disease in elderly people with a rate of 15.8% (tinea pedis, 56%). In elderly people, pruritus is most frequently seen and disturbing complaint. Another study demonstrated significant correlation between severity of pruritus and quality of life in elderly people.24 According to our results, 40.2% of all subjects constituted people at 50 years old and older. Mean score of DLQI and MPI in subjects at 50-59 years was significantly higher compared to other age groups.

Presence of systemic disease and its characteristics play role in development of tinea pedis. Diabetes mellitus is especially a significant health problem with increasing Incidence globally and improving quality of life by its complications. Tinea pedis cases constitute 30% of cutaneous fungal infections in patients with Diabetes Mellitus (DM)9,25 In case of untreated onycomycosis and tinea pedis in diabetic patients, impaired tissue integrity results in serious bacterial infections, foot ulcers and more importantly diabetic foot picture which in turn reduce more patient quality of life.9 In our study, we also determined that tinea pedis increased pruritus score and negatively affected quality of life in DM patients.

According to our study results, disease duration is also an important factor affecting MPI and DLQI. Also patients with disease longer than a year, have higher mean score of MPI and DLQI. This suggests that longer disease duration is related with more affected patient by disease related symptoms. Yıldırım et al.3 also indicated that quality of life is more impacted by longer duration of superficial fungal diseases.

Study results demonstrated that mean DLQI and MPI score was higher in patients with physical symptoms such as redness, pain, swelling, ache, bleeding, exfoliation, pruritus, burning sensation at foot, scall on nail and nail thickness than asymptomatic patients and that this difference between them was statistically significant. In addition, as number of disease specific symptoms increased, DLQI and MPI mean scores were also increased. Szepietowski et al.18 studied the impact of onychomycosis on quality of life and indicated that quality of life was negatively affected in patients with symptoms such as color change of nails, thickening and pain. We consider that symptoms negatively affecting physical and psychological condition and leading to increased cost and management of these symptoms should be among priority topics in this field.

Mean score of DLQI and MPI increased by increasing severity of pruritus and patients with more severe pruritus had significantly higher mean score of DLQI and MPI and therefore pruritus was considered to be an important parameter with impact on quality of life. In few studies measuring quality of life in dermatological diseases, main factor affecting quality of life was pruritus. In a study of Sánchez-Pérez et al.26 sleep quality, pruritus and quality of life were assessed in 323 patients with diagnosis of atopic dermatitis and they found that pruritus reduced quality of life, thus quality of life was negatively affected.

In another study of Balcı et al.4 DLQI in patients with liken planus and pruritus was suggested to affect primarily the quality of life of patients. In study of Ertürk where the impact of dermatosis with itching on quality of life was investigated, score for quality of life was increased by increasing pruritus score of patients and negative impact of pruritus on quality of life has been emphasized.5

Although tinea pedis is among the most frequently encountered dermatological diseases, number of studies on the effect on quality of life is very few. In a study by Yıldırım et al.3 DLQI was applied to 120 patients with superficial mycosis and quality of life in patients with tinea pedis and tinea inguinalis was more affected than patients with tinea versicolor. Among all patients, 87% reported that their quality of life was negatively affected as “a little”; 77% of patients complained from pruritus, 41% from treatments and 36% of patients complained the impact of disease on their turnout; 40% of patients reported that they felt shamed for their disease, 7% of patients reported that disease negatively affect their sexual life and 13% reported their professional life was negatively affected. Although not mentioned in above studies, we consider that slight pruritus or lack of pruritus may less affect quality of life in patients with tinea versicolor.27

With ethical standards

Funding

The author(s) received no financial support for the research, authorship, and/or publication of this article.

Informed consent

Patients were informed about the study objective and were assured that their identity will not be disclosed, and then written informed consent was obtained from each patient.

Ethical approval

Ethics principles were followed during whole study process. Before initiation of study, approval of Erciyes University Clinical Trials Ethics Committee (2016/412) and necessary written permission form institutional board of Kayseri State Hospitals Association General Secretariat Kayseri research and Training Hospital (52332816/) were obtained.

Conclusion

In conclusion, in our study we observed that quality of life was reduced especially in female patients at middle age years and in whom systemic disease, prolonged disease duration and symptomatic patients. In addition all studies suggested that pruritus which is the moıst frequent and most uncomfortable dermatological symptom impaired significantly the quality of life. Dermatological and general well-being symptoms should be managed collectively in order to maintain daily activities and insights. We believe in that life standards of patients will be increased by increasing awareness of negative effects of pruritus in patients with tinea pedis and by a multidisciplinary collaboration.

Acknowledgments

None.

Conflict of interest

The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

References

  1. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skinmycoses worldwide. Mycoses. 2008;51:2–15.
  2. Seçkin HY, Baş Y, Takçı Z, et al. Prevalence of tinea pedis and onychomycosis in the region of Tokat. Gaziosmanpaşa University Journal of Medical Faculty. 2014;6:176–184.
  3. Yıldırım M, Baysal VA, Tenekeci HÖ. Quality of life in patients with superficial mycosis. Süleyman Demirel University Journal of Medical Faculty. 2004;11:15–17.
  4. Balcı DD, İnandı T. Dermatology life quality ındex scores in lichen planus: comparison of psoriasis and healthy controls. Türkderm. 2008;42:127–130.
  5. Ertük İ. The effect of the prurıtus on the qualıty of lıfe in prurıtıc dermatologıc dıseases. Trakya university faculty of medicine department of dermatology, Master Thesis; 2009
  6. Perea S, Ramos MJ, Garau M, et al. Prevalence and risk factors of tinea unguium and tinea pedis in the general population in Spain. J Clin Microbiol. 2000;38:3226–3230.
  7. Bender B. Psychological dysfunction associated with atopic dermatitis. Immunol Allergy Clin North Am. 2002;22:43–53.
  8. Sahoo AK, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis. A comprehensive review. Indian Dermatol Online J. 2016;7(2):77–86.
  9. İnan E. The prevalence of onychomycosis and tinea pedis, causative fungus in diabetes mellitus. çukurova university faculty of medicine department of dermatology, Master Thesis, Adana; 2009.
  10. Zachariae R, Zachariae H, Blomqvist K, et al. Quality of life in 6497 Nordic patients with psoriasis. Br J Dermatol. 2002;146: 1006–1016.
  11. Finlay AY, Khan GK. Dermatology life quality ındex (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–216.
  12. Gurel MS, Yanık M, Şimşek Z, et al. Quality of life instrument for Turkish people with skin diseases. Int J Dermatol. 2005;44: 933–938.
  13. Desai NS, Poindexter GB, Monthrope YM, et al. A pilot quality-of-life instrument for pruritus. J Am Acad Dermatol. 2008;59: 234–244.
  14. Aksu AE, Urer MS, Sabuncu I, et al. Turkish version of Skindex-29. Int J Dermatol. 2007;46:350–355.
  15. William DJ, Timothy GB, Dirk ME. Andrews’diseases of the skin. Clinical Dermatology. 2008;1:297–333.
  16. Weinstein A, Berman B. Topical treatment of common superficial tinea infections. Am Fam Physician. 2002;65:2095–2102.
  17. Ständer S, Stumpf A, Osada N, et al. Gender differences in chronic pruritus: women present different morbidity, more scratch lesions and higher burden. Br J Dermatol. 2013;168:1273–1280.
  18. Szepietowski JC, Reich A, Pacan P, et al. Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis-specific questionnaire. J Eur Acad Dermatol Venereol. 2007;21:491–496.
  19. Erdem Y, Özarmağan G. Evaluation of the quality of life in patients with genital warts. Turkderm-Arch Turk Dermatol Venerology. 2016;50:21–24.
  20. Baykal Y, Karaduman A, Bükülmez D. Skin problems in elderly patıents. Turkish Journal of Geriatrics. 1999;2:156–159.
  21. Ovayolu N, Ovayolu Ö. Basic ınternal medicine nursing and chronic diseases with different dimensions. In: Biçer S. editors, health problems in elderly people and nursing approaches. Nobel Medical Bookstore. 2016;572–585.
  22. Özyurt K, Avcı A, Çınar SL, et al. Dermatological disorders in geriatric patients. Turk J Dermatol. 2014;4:206–209.
  23. Yalçin B, Tamer E, Toy GG, et al. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol. 2006;45(6):672–676.
  24. Teoh YL, Teo RY, Yeo B, et al. Elderly hospitalised patients-the ımpact of ıtch and its prevalence. Ann Acad Med Singapore. 2016;45:134–137.
  25. Akkuş G, Evran M, Güngör D, et al. Tinea pedis and onychomycosis frequency in diabetes mellitus patients and diabetic foot ulcers. A cross sectional–observational study. Pak J Med Sci. 2016;32(4):891–895.
  26. Sánchez PJ, Daudén TE, Mora AM, et al. Impact of atopic dermatitis on health-related quality of life in Spanish children and adults: the PSEDA study. Actas Dermosifiliogr. 2013;104:44–52.
  27. Gupta AK, Ryder JE, Nicol K, et al. Superficial fungal infections: an update on pityriasis versicolor, seborrheic dermatitis, tinea capitis and onychomycosis. Clin Dermatol. 2003;21:417–425.
Creative Commons Attribution License

©2018 Biçer, et al. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.